ARGENT BIOPHARMA LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of H5O0 for the last semiannual is 181.44 k EUR, and it's 50.93% lower compared to the previous semiannual. The net income of H2 24 is -6.51 M EUR.